Month: February 2021

SAN MATEO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., is pleased to announce today that, further to its press release dated February 3, 2021, holders (the “Debentureholders”) of the Company’s 8.00% unsecured convertible debentures due February 28, 2021 (the “Debentures”) have approved by way of signed instruments in writing in the form of the Form of Proxy, certain proposed amendments to the terms of the Debentures (the “Debenture Amendments”) and proposed resolutions for consideration (the “Resolution Amendments” and together with the Debenture Amendments, the “Amendments”). The Amendments have therefore been validly approved.As a result of such approval, the extraordinary meeting of Debentureholders...

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) — Today, DraftKings (Nasdaq: DKNG) announced the appointment of baseball legend and entrepreneur Cal Ripken Jr. as a special advisor to the board of directors. Ripken will lend strategic insights to the board of directors and Chief Executive Officer on key company initiatives and will become a DraftKings equity holder.Ripken enjoyed a Hall of Fame Major League Baseball career and is one of only ten players in history with more than 3,000 hits and 400 home runs. He has won a World Series championship, two AL MVP Awards, two AL All-Star Game MVP Awards, two Gold Gloves, made 19 All-Star Game appearances and captured eight Silver Slugger Awards. However, he is most well known for his incredible streak of 2,632 consecutive games played which made him baseball’s all-time “Iron Man.” Since retiring...

DUBLIN, Ireland and TREVOSE, Pa., Feb. 25, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will host a conference call with members of Strongbridge’s management team on Wednesday, March 3, 2021 at 8:30 a.m. ET to discuss the Company’s fourth quarter and full-year 2020 financial results and corporate highlights. The conference call will follow the anticipated release of the Company’s financial results earlier that day.Event DetailsStrongbridge will host a conference call on Wednesday, March 3, 2021 at 8:30 a.m. ET. To access the live call, dial (844) 285-7153 (domestic) or (478) 219-0180 (international) with conference 2452827....

Full year consolidated sales increased 9.0% from prior year periodFull year operating income increased 14.8%; Adjusted operating income up 20.9%ATCHISON, Kan., Feb. 25, 2021 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today reported results for the fourth quarter and full year ended December 31, 2020.2020 fourth quarter results compared to 2019 fourth quarter resultsConsolidated sales increased 9.1% to $100.9 million, as a result of double-digit growth in both premium beverage alcohol and the Ingredient Solutions segment.Consolidated gross profit increased 47.2% to a record $31.7 million, representing 31.4% of consolidated sales, due to improved segment gross profits in both the Distillery Products and Ingredients Solutions segments.Consolidated...

BALTIMORE, Feb. 25, 2021 (GLOBE NEWSWIRE) — Laureate Education, Inc. (NASDAQ: LAUR) today announced financial results for the fourth quarter and the year ended December 31, 2020.Unless indicated otherwise, the results presented below relate to Continuing Operations, which encompass Laureate’s operations in Mexico and Peru, as well as Laureate’s Corporate overhead expenses.Fourth Quarter 2020 Highlights (compared to fourth quarter 2019):On a reported basis, revenue decreased 19% to $285.2 million. On an organic constant currency basis¹, revenue decreased by 13%.Operating income for the fourth quarter decreased by $20.4 million, or 36%, to $36.9 million.Net income (including Discontinued Operations) for the fourth quarter was $379.0 million, primarily attributable to the gain on sale of the Company’s Australia and...

– Outlined strategy to build integrated cell therapy company and the Company’s “2-2-5-2” five-year core value drivers –– Reported compelling durable responses in patients with synovial sarcoma, and initial responses in lung, head and neck, liver, esophagogastric junction, and melanoma cancers confirming potential of SPEAR T-cells for solid tumors –– Completed enrollment of SPEARHEAD-1 clinical trial, to support planned BLA filing and commercialization in 2022 for ADP-A2M4 for people with synovial sarcoma –– Initiating Phase 2 trial (SURPASS-2) with ADP-A2M4CD8 in esophageal and esophagogastric junction cancers in 1H 2021 –– Demonstrated killing of cancer cells with T-cells derived from the Company’s allogeneic platform. MAGE-A4 and mesothelin to be first allogeneic programs into the...

VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV: OSI) (FSE: RSR1) (OTCQB: OSIIF) (“Osino” or “the Company”) is pleased to announce that management will be participating in the 30th annual BMO Global Metals & Mining Conference March 1 – 5, 2021.Heye Daun, CEO of Osino, will be presenting on Thursday, March 4th at 12:00pm ET. Members of management will also be participating in institutional investor meetings during the week.The BMO Global Metals & Mining Conference is one of the sector’s premier mining conferences and for the first time will be hosted digitally. This five-day invitation-only conference brings together mining industry leaders and institutional investors from around the globe. The conference is hosted by the BMO Capital Markets’ Metals & Mining Equity Research...

SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management will participate in three upcoming virtual conferences:A fireside chat at the Cowen 41st Annual Health Care Conference on March 4, 2021 at 12:50 p.m. ET / 9:50 a.m. PT;A pre-recorded presentation at the H.C. Wainwright Global Life Sciences Conference available on-demand starting at 7 a.m. ET / 4 a.m. PT on March 9, 2021; andA presentation at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 at 11:20 a.m. ET / 8:20 a.m. PT.Live audio webcasts will be available through the Events page of the company’s website (www.otonomy.com).About OtonomyContacts:Media InquiriesSpectrum ScienceChloé-Anne RamseyVice President404.865.3601cramsey@spectrumscience.comInvestor...

– B-SIMPLE4 pivotal Phase 3 trial evaluating SB206 as a treatment for molluscum contagiosum progressing with top-line efficacy results targeted before the end of Q2 2021 –– Company targeting initiating preclinical studies for intranasal formulation of berdazimer sodium for COVID-19 program, SB019, in Q1 2021 –– Ongoing evaluations for strategic partnering opportunities to leverage broader pipeline to secure next phase of growth –MORRISVILLE, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced its financial and operating results for the year ended December 31, 2020 and provided a corporate update.“With our accomplishments achieved over the course of 2020 and our near-term milestones ahead of us this year, we believe we are well-positioned for an exciting 2021. As enrollment...

Delivering on our commitment to shareholders with two transformative transactionsIain Ross, CEO, Golar LNG, said:“Golar is pleased to report Q4 total operating revenues of $118.7 million, adjusted EBITDA1 of $78.0 million and net income of $9.5 million, driven by another quarter of uninterrupted commercial uptime in FLNG and a Q4 Adjusted TCE1 for the shipping fleet at $51,800 per day.Previously announced sales of Hygo Energy Transition Ltd. (“Hygo”) and Golar LNG Partners LP (“Golar Partners” or “the Partnership”) to New Fortress Energy Inc. (“NFE”), in transactions with a combined enterprise value of approximately $5 billion, deliver on Golar’s commitment to simplify its corporate structure and crystallize value to Golar shareholders. The combination of NFE, Hygo and Golar Partners will also create the leading LNG downstream distribution...